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Notch signaling is involved in a variety of cell-fate decisions during development. Here we investigate the role of Notch signaling in
apoptotic cell death of neural progenitors through the generation and analysis of cell type-specific conditional transgenic and knockout mice.
We show that conditional expression of a constitutively active form of Notch1 in early neural progenitor cells, but not postmitotic neurons,
selectively induces extensive apoptosis, resulting in a markedly reduced progenitor population. Conversely, attenuation of Notch signaling in
Notch1 conditional knockout or Presenilin-1/ mice results in reduced apoptosis of early neural progenitor cells. Furthermore, Notch
activation in neural progenitor cells leads to elevated levels of nuclear p53 and transcriptional upregulation of the target genes Bax and Noxa,
and the promotion of apoptotic cell death by Notch activation is completely suppressed by p53 deficiency. Together, these complementary
gain-of-function and loss-of-function studies reveal a previously unappreciated role of Notch signaling in the regulation of apoptotic cell
death during early mammalian neural development.
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Notch signaling is an evolutionarily conserved signaling
pathway that mediates cell–cell interactions required for a
variety of cell-fate decisions during development (Artava-
nis-Tsakonas et al., 1999; Justice and Jan, 2002). Notch
receptors are activated upon ligand binding from neighbor-
ing cells and then proteolytically processed by an ADAM/
TACE family metalloprotease (Brou et al., 2000; Mumm et
al., 2000) followed by a presenilin-dependent protease to
release the Notch intracellular domain (NICD) (De Strooper
et al., 1999; Schroeter et al., 1998; Song et al., 1999; Struhl0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: jshen@rics.bwh.harvard.edu (J. Shen).and Greenwald, 1999; Ye et al., 1999). NICD translocates
into the nucleus and activates transcription of its down-
stream targets primarily by forming a complex with CSL
(CBF1/RBP-Jn, Suppressor of hairless, Lag-1) (Greenwald,
1998; Kimble and Simpson, 1997; Mumm and Kopan,
2000; Weinmaster, 1998). Within the cell, Notch activity
can also be regulated through ubiquitin-mediated proteolysis
involving the E3 ligases SEL-10 (Gupta-Rossi et al., 2001;
Oberg et al., 2001; Wu et al., 2001), Itch (McGill and
McGlade, 2003; Qiu et al., 2000), or Suppressor of deltex
(Cornell et al., 1999).
During mammalian neural development, activation of
the Notch signaling pathway is known to be involved in the
maintenance of neural progenitor identity and the suppres-
sion of neuronal differentiation (Schuurmans and Guille-
mot, 2002). Targeted disruption of Notch1 or RBP-Jj in
mice results in upregulation of pro-neuronal transcription
factors and depletion of neural progenitor cells (Conlon et
al., 1995; de la Pompa et al., 1997; Hitoshi et al., 2002;
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Notch signaling in Presenilin-1 (PS1) null mice leads to
premature neuronal differentiation and subsequently re-
duced neural progenitor and neuronal populations (Handler
et al., 2000; Hitoshi et al., 2002; Shen et al., 1997). The
role of Notch signaling in the maintenance of neural
progenitor cells is further supported by gain-of-function
studies showing that Notch activation prevents neuronal
differentiation (Chambers et al., 2001; Dorsky et al., 1995;
Henrique et al., 1997; Hitoshi et al., 2002; Nye et al., 1994;
Scheer et al., 2001).
More recently, Notch signaling has been shown to
influence gliogenesis (Gaiano and Fishell, 2002; Lundkvist
and Lendahl, 2001; Morrison, 2001; Wang and Barres,
2000). In the peripheral nervous system, Notch signaling
acts instructively in neural crest stem cells to promote an
irreversible switch to gliogenesis (Morrison et al., 2000). In
the central nervous system (CNS), activated Notch1 and 3 in
multipotent progenitor cells derived from adult hippocam-
pus also favors astroglial differentiation (Tanigaki et al.,
2001). Notch activation similarly promotes the generation of
Mu¨ller glia in the retina (Furukawa et al., 2000; Hojo et al.,
2000; Scheer et al., 2001). In the mouse telencephalon, one
study has shown that Notch activation promotes radial glial
identity (Gaiano et al., 2000). Subsequent findings indicate
that radial glia can cause both neurons and glia (Hartfuss et
al., 2001; Malatesta et al., 2000; Miyata et al., 2001; Noctor
et al., 2001), making it less clear whether Notch signaling
promotes terminal glial differentiation in the embryonic
forebrain (Schuurmans and Guillemot, 2002). Another study
found that the consequence of Notch activation in neural
progenitor cells is dependent upon their temporal and spatial
context: it drives progenitor cells into a nondifferentiating,
nonmigratory, quiescent state at an earlier developmental
stage, while it promotes proliferation of glia at later stages
(Chambers et al., 2001).
In addition to neurogenesis and gliogenesis, Notch sig-
naling regulates cell proliferation in a cell type-dependent
manner. Its activation can increase proliferation in mamma-
lian astrocytes (Chambers et al., 2001; Furukawa et al.,
2000; Tanigaki et al., 2001) and Drosophila wing disc cells
(Baonza et al., 2000), and can cause T cell lymphoma
(Ellisen et al., 1991) and mammary tumors (Jhappan et
al., 1992). Conversely, Notch activation promotes cell cycle
arrest in the vertebrate retina (Dorsky et al., 1995; Scheer et
al., 2001), telencephalon (Chambers et al., 2001), and
keratinocytes (Rangarajan et al., 2001), which is in agree-
ment with findings showing that loss of Notch1 and PS1 in
the mouse skin results in development of tumors (Nicolas et
al., 2003; Xia et al., 2001).
The effect of Notch activation on apoptotic cell death is
also highly cell type-specific. It promotes cell death in the
Drosophila retina (Cagan and Ready, 1989; Miller and
Cagan, 1998; Yu et al., 2002), wing imaginal disc (Milan
et al., 2002), and sensory organ (Orgogozo et al., 2002). In
the zebrafish retina, Notch activation plays a similar pro-apoptotic role (Scheer et al., 2001). In mammalian lympho-
cyte development, Notch signaling serves as a binary switch
influencing apoptotic cell death: it protects T cells from
apoptosis (Deftos et al., 1998; Jehn et al., 1999; Miele and
Osborne, 1999) while promoting apoptosis in B cells
(Morimura et al., 2000). These observations raise the
possibility that during mammalian neural development,
Notch signaling may play a role in the regulation of
apoptotic cell death, which is an important mechanism that
controls the size and shape of the nervous system (Kuan et
al., 2000). However, there has been no report demonstrating
an involvement of Notch signaling in apoptosis during
mammalian neural development.
All of the mammalian gain-of-function studies described
above employed retroviral infection or transfection
approaches to express NICD in a small percentage of neural
progenitor cells, which is advantageous for tracing distinct
neuronal or glial fates of infected progenitors, but it is
technically difficult to trace the progeny of the infected
cells that have undergone cell death. To overcome this
limitation and to determine whether Notch activation is
involved in the regulation of apoptotic cell death in neural
progenitor cells or postmitotic neurons, we took advantage
of a cell type-specific conditional transgenic approach
which allows expression of NICD in most, if not all, neural
progenitor cells (NPC-NICD) or postmitotic neurons (PN-
NICD) in mice. Here we show that expression of the
intracellular domain of Notch1 in neural progenitor cells,
but not postmitotic neurons, selectively induces extensive
apoptotic cell death in a subset of progenitor cells, resulting
in marked reduction in both neural progenitor and neuronal
population. Notch activation promotes apoptotic cell death
via a p53-dependent pathway as demonstrated by upregu-
lation of the p53 pathway in NPC-NICD mice and the
complete suppression of apoptotic cell death by p53 defi-
ciency. To complement our gain-of-function genetic ap-
proach, we furthered our study to loss-of-function mutant
mice. Attenuation of Notch activity in Notch1 conditional
knockout (cKO) or PS1-null mice results in a marked
reduction in cell death of early neural progenitor cells.
Together, these results show that Notch signaling plays a
physiological role in the regulation of programmed cell
death of neural progenitors during early mammalian neural
development.Material and methods
Generation of Notch1 conditional transgenic and knockout
mice
The human NICD (amino acid residues 1762–2304),
including the RAM23 domain, CDC10/Ankyrin repeats,
and two nuclear localization signals, was generated by PCR
using a vector containing full-length human Notch1 cDNA
(gift of Dr. S. Artavanis-Tsakonas). The cDNA sequence
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The cDNA, together with an SV40 late polyadenylation
signal, was cloned into the restriction sites following the
floxed ‘‘stop’’ cassette of the chicken h-actin-loxP-stop-
loxP (pCALSL) vector (gift of Dr. R. Kelleher). The
transgene was injected into the pronucleus of C57BL/6J
embryos to obtain CALSL-NICD transgenic mice. Southern
analysis was performed on six independent lines of trans-
genic mice to determine the number of the transgene
insertion sites, approximate copy numbers of the transgene,
and the orientation of the transgenes relative to one another.
We eliminated four of the six lines that may carry trans-
genes in two or more insertion sites because Cre recombi-
nase can potentially mediate site-specific recombination
between any two loxP sites present in these insertion sites,
resulting in large chromosomal deletions. The remaining
two lines carrying transgenes in a head-to-tail orientation in
a single insertion site were selected for further character-
ization. Both lines were further confirmed by PCR to carry
intact transgenes in a head to tail orientation and were
termed CALSL-NICD (H) (high; 10–20 copies) and
CALSL-NICD (L) (low; 1–2 copies) lines. Each of the
two lines was then bred to Nestin-Cre (Nes-Cre) mice
(Tronche et al., 1999), which were generated in C57BL/
6J and SJL hybrid and backcrossed to C57BL/6J mice for
more than 10 generations, to obtain CALSL-NICD;Nes-Cre
(NPC-NICD) mice. Because the expression level of NICD
in the NPC-NICD (L) line was below detection by Western
and immunohistochemical analyses, the NPC-NICD (H)
line, which expressed detectable but very low levels of
NICD, was selected to assess the effects of Notch activa-
tion in neural progenitor cells. To simplify the nomencla-
ture, ‘‘(H)’’ was omitted henceforth, while transgenic mice
carrying the (L) locus were always specified. Similarly,
CALSL-NICD mice were crossed with Synapsin I-Cre (Syn-
Cre) mice (Zhu et al., 2001) to generate CALSL-NICD;Syn-
Cre (PN-NICD) mice.
For the generation of CALSL-NICD;Nes-Cre;p53/
mice, CALSL-NICD and Nes-Cre mice were crossed to
p53/ mice (Jackson Laboratory) (Jacks et al., 1994) to
obtain CALSL-NICD; p53+/ and Nes-Cre; p53+/ mice,
respectively. Further crossing to p53/ mice to obtain
CALSL-NICD;p53/ or Nes-Cre;p53/ mice was made
difficult due to the incomplete penetrance of lethality and
exencephaly associated with p53/ mice (Armstrong et
al., 1995). Therefore, CALSL-NICD;p53+/ mice were
crossed with Nes-Cre;p53+/ mice to generate CALSL-
NICD;Nes-Cre;p53/ mice. Genotyping revealed that
even at E10.5–11.5, the ratio of CALSL-NICD;Nes-
Cre;p53/ (approximately 1/20) was lower than the
expected Mendelian ratio of 1/16. The usable CALSL-
NICD; Nes-Cre; p53/ embryos were further reduced
to approximately 1/30 due to exencephaly in a subset of
p53/ embryos (Armstrong et al., 1995; Sah et al., 1995).
A modified Notch1 allele was generated similarly as
described in a previous report (Radtke et al., 1999).Briefly, the targeting vector containing a floxed PGK-neo
selection cassette and a loxP site in the upstream and
downstream of the first coding exon was transfected into
RW-4 ES cells (Simpson et al., 1997). The floxed Notch1
allele (fN1) was then generated by transient transfection of
a cDNA encoding Cre recombinase. Removal of the floxed
PGK-neo cassette in ES cells was confirmed by PCR and
Southern analyses. ES cells carrying the fN1 allele were
injected into mouse blastocysts to generate chimeric mice,
which were then used to generate homozygous fN1 mice.
The fN1 mouse was then crossed with Nes-Cre transgenic
mice to generate Notch1 conditional knockout (N1 cKO)
mice.
Preparation of embryos and brain sections
Embryos at day 9.5 (E9.5, 23 pairs of somites) and E10.0
(29 pairs of somites) were fixed in 4% paraformaldehyde
overnight at 4jC and then processed for whole-mount in
situ hybridization. For brain sections, embryos were fixed in
4% paraformaldehyde at 4jC for 40 min (E10.0), 1.5
h (E11.5), or 2 h (E12.5 and 13.5), cryoprotected, embedded
in OCT, and then sectioned at 7 Am. For embryos between
9.0 and 10.0, only those with identical number of somites
were used. In addition, for p53/ mice, only those
embryos with properly closed neural tube were used for
analysis.
Immunostaining and in situ hybridization
For immunostainings, sections were blocked with a
solution containing 1% BSA, 3% goat serum, and 0.1%
Triton X-100 for 3 h at room temperature, and incubated
with desired primary antibodies overnight at 4jC. The
following primary antisera or antibodies were used: anti-
activated-caspase-3 rabbit antiserum (1:300, Cell Signaling
Technology), anti-h-tubulin III antibody (1:100, Sigma),
anti-p53 rabbit antiserum (1:100, Santa Cruz Biotechnolo-
gy), and anti-mouse NICD antiserum (1:800, gift of Dr. A.
Israel). Sections were then washed in PBS and incubated
with appropriate Alexa Fluor 488- or Alexa Fluor 594-
conjugated secondary antibodies (1:300, Molecular Probes)
for 2 h at room temperature. Images were viewed on a Zeiss
Axioskop and collected with a SPOT 2 Cooled Color
Digital camera (Diagnostic Instruments) or a Zeiss confocal
laser scanning microscope. Whole-mount in situ hybridiza-
tion and in situ hybridization of brain sections were per-
formed as described in Handler et al. (2000) using probes
specific for full-length Cre or the stop cassette.
TUNEL assay and quantification of apoptotic cells
TUNEL assay was performed on comparable brain
sections at E10.0 and E11.5 as described in Handler et al.
(2000). At E11.5, the number of apoptotic cells was quan-
tified by counting three serial sections per brain in the entire
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number of apoptotic cells in the forebrain–midbrain junc-
tion was quantified by counting three serial sections per
brain using a micrometer grid eyepiece to select an area of
320  320 Am2 that encompasses all TUNEL+ cells in this
region. Statistical significance was determined by Student’s
t test.
Real-time quantitative RT-PCR
Brains at E11.5 were collected for the preparation of total
RNA using Tri Reagent (Sigma). The cDNA was synthe-
sized using Superscript II first-strand cDNA synthesis
system (Gibco BRL). Oligonucleotide primers were
designed using Primer Express software 1.0 (Applied Bio-
systems). The specificity of primers was determined by gel
electrophoresis of PCR products to ensure a single band
with predicted size. Quantitative PCR reaction was per-
formed using SYBR Green on an ABI PRISM 7700
Sequence Detection System (Applied Biosystems). Relative
quantification of gene expression was performed using
Comparative CT method according to manufacturer’s rec-
ommended protocol (User Bulletin #2, ABI PRISM 7700
Sequence Detection System, Perkin-Elmer). Levels of target
mRNA are normalized according to 18S rRNA. The change
of the expression of a target gene in the NPC-NICD brain
relative to the littermate control is calculated as: fold change
= 2(DCT,TgDCT,control).Fig. 1. Generation of NPC-NICD mice. (A) The CALSL-NICD transgene
contains the chicken b-actin promoter, a hybrid 5Vintron, a transcriptional
and translational stop cassette flanked by two loxP sites, cDNA encoding
human NICD (amino acid residues 1762–2304), and the SV40 poly-
adenylation signal. In CALSL-NICD transgenic mice, transcription and
translation of the NICD cDNA are blocked by multiple polyadenylation
sites and stop codon present in the stop cassette. In the presence of Cre
recombinase, the stop cassette is excised, thus allowing the transcription
and translation of NICD (see arrow). P1, P2, and P3 are PCR primers used
to confirm the excision of the stop cassette. (B and C) Whole-mount in situ
hybridization analysis of CALSL-NICD and wild-type embryos at E9.5. The
stop cassette transcript is ubiquitously expressed in CALSL-NICD
transgenic mice. (D and E) Whole-mount in situ hybridization analysis of
Nes-Cre and wild-type embryos at E9.5. The Cre transcript is expressed in
the forebrain (fb, telencephalon and diencephalon), midbrain (mb,
mesencephalon), and hindbrain (hb, metencephalon and myelencephalon)
of Nes-Cre transgenic mice. (F and G) Whole-mount in situ hybridization
analysis of NPC-NICD double transgenic mice (G) and CALSL-NICD
single transgenic control (F) at E10.0. Cre is expressed broadly in the
forebrain, midbrain, and hindbrain of NPC-NICD mice. (H) Western
analysis of E13.5 brain extracts revealed a doublet band corresponding to
the appropriate size of NICD in NPC-NICD (lane 2) but not control mice
(lane 1). (I –L) Immunohistochemical analysis of the control and NPC-
NICD telencephalon at E11.5 using the IC antiserum (green) double labeled
with a nuclear dye, TOPRO-3 (red). In contrast to the below detection level
of endogenous NICD in the nucleus of most progenitor cells in control mice
(I and K), most live progenitor cells in the NPC-NICD telencephalon
express detectable levels of NICD in their nuclei (J and L). (M) Higher
power view of the boxed area in L. Arrows indicate nuclei that are in
yellow, resulting from overlapping NICD immunoreactivity (green) and
nuclear DNA labeling (red). Scale bar: 100 Am.Results
Generation of conditional NICD transgenic mice
Previous studies in Drosophila and zebrafish have shown
that Notch is involved in apoptotic cell death of certain cell
populations in the developing retina (Cagan and Ready,
1989; Miller and Cagan, 1998; Scheer et al., 2001) and
Fig. 2. Markedly reduced brain size in NPC-NICD mice. (A–D) Gross
morphology of NPC-NICD and control (wild-type or single transgenic
littermates) brains at P0 and E13.5. NPC-NICD mice exhibit a smaller
brain, especially the cerebral cortex or telencephalon. Arrows indicate the
telencephalon. (E and F) Hematoxylin and eosin staining of NPC-NICD
and control brain sections at E13.5. All brain subregions are markedly
reduced in NPC-NICD mice.
Fig. 3. Extensive apoptosis induced by NICD in early neural progenitor
cells. (A–D) In situ hybridization and TUNEL staining of control and
NPC-NICD brain sections at E10.0. Cre is expressed in the forebrain–
midbrain junction of NPC-NICD mice (C), where extensive apoptosis is
observed (D). (E and F) Higher power views of the boxed areas in B and D,
respectively. (G and H) Increased apoptosis is also revealed by increased
activated Caspase-3 immunoreactivity. (I and J) TUNEL staining of the
control (I) and NPC-NICD (J) telencephalon at E11.5, when apoptosis is
most severe. Scale bar: 200 Am.
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signaling regulates cell death in the developing mammalian
brain, however, was unknown. Gain-of-function studies
employing retroviral approaches to express NICD in neural
progenitor cells showed that expression of NICD at E9.5
promotes radial glial lineage (Gaiano et al., 2000), while
expression of NICD at E14.5 results in cessation of prolif-
eration of progenitor cells and dramatic reduction of neuro-
nal generation, and subsequently increased glial prolifera-
tion leading to overproduction of glia (Chambers et al.,
2001). The advantage of the retroviral approach is the
readily imposable temporal control of NICD expression,
while the disadvantages are that only a small percentage of
neural progenitor cells can be infected by retroviruses and
that the infected cells are traced by expression of marker or
reporter genes, making it technically difficult to determine
which fraction of the infected cells have undergone cell
death. To circumvent this technical limitation, we chose to
use a transgenic approach expressing the intracellular do-
main of Notch1 in most, if not all, neural progenitor cells to
determine the consequences of Notch activation in neural
progenitor cells. Because expression of the intracellular
domain of Notch3 under the direct control of the Nestin
promoter resulted in early embryonic lethality, which pre-
cluded establishment of transgenic lines for further analysis
(Lardelli et al., 1996), we took advantage of the Cre/loxPtechnology for recombination-activated transgene expres-
sion (Lakso et al., 1992) to generate conditional transgenic
mice that express the intracellular domain of Notch1 either
in neural progenitor cells or in postmitotic neurons.
We first generated CALSL-NICD transgenic mice in
which NICD expression is under the control of the chicken
b-actin promoter and a floxed transcriptional and transla-
tional ‘‘stop’’ cassette (Fig. 1A). Two independent lines of
transgenic mice, which were confirmed by Southern and
PCR analyses to carry intact transgenes in a head-to-tail
fashion in a single insertion site, were designated CALSL-
NICD (H) (high; 10–20 copies) and CALSL-NICD (L) (low;
1–2 copies) lines. Both lines were crossed with Nes-Cre
mice (Tronche et al., 1999) to obtain CALSL-NICD;Nes-Cre
(H) and CALSL-NICD;Nes-Cre (L) mice. To simplify the
nomenclature, CALSL-NICD (H) and CALSL-NICD;Nes-
Cre (H) mice are termed CALSL-NICD and NPC-NICD
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(L) mice are always specified.
Whole-mount in situ hybridization analysis of CALSL-
NICD embryos at E9.0 and 9.5 (18 and 23 pairs of somites)
using the stop cassette sequence as probe confirmed ubiq-
uitous expression of the stop transcript driven by the
chicken b-actin promoter (Figs. 1B and C, data not shown).
The spatial and temporal pattern of Cre expression was
determined by in situ hybridization analysis of Nes-Cre and
CALSL-NICD;Nes-Cre mice. The Cre transcript was al-
ready detectable at E9.0 (18 pairs of somites) in the spinal
cord and the forebrain–midbrain junction (data not shown).
At E9.5 (23 pairs of somites), Cre expression extended to
the diencephalon, mesencephalon, and metencephalon
(Figs. 1D and E). By E10.0 (29 pairs of somites), Cre
expression was evident throughout the CNS, though its
expression appeared to be more restricted in the telenceph-
alon and was highest in the forebrain–midbrain junction
(area connecting the diencephalon and mesencephalon)
(Figs. 1F and G). This expression pattern is consistent with
a previous report in which a lacZ transgene was expressed
under the control of the same Nestin promoter and regula-
tory sequences (Zimmerman et al., 1994). We further
confirmed the excision of the ‘‘stop’’ cassette in the
CALSL-NICD;Nes-Cre brain at E9.5 (23 pairs of somites)
by PCR using three primers specific for the 5Vintron, ‘‘stop’’
cassette, and NICD coding sequence (Fig. 1A, data not
shown). In addition, it was demonstrated previously that
Cre-mediated site-specific recombination occurs in neural
progenitor cells localized in the ventricular zone during
early embryonic development using the same Nes-Cre
mouse crossed with a ROSA26 reporter mouse (Graus-Porta
et al., 2001).
RT-PCR analysis revealed higher levels of the NICD
transcript in NPC-NICD mice than in NPC-NICD (L) mice
at E11 (data not shown). Western analysis using an antise-Fig. 4. Expression of NICD in postmitotic neurons does not promote apoptosis. (A
mice at E13.5 using the IC antiserum. NICD is highly expressed in postmitotic neu
staining reveals no increase in apoptosis in the PN-NICD brain. Scale bar: 200 Arum (IC) specific for the intracellular domain of Notch1
detected very low levels of NICD in NPC-NICD but not in
control or NPC-NICD (L) brains, whereas levels of furin-
cleaved products (p120) were similar (Fig. 1H and data not
shown). We then performed immunohistochemical analysis
using the IC antiserum which could detect all Notch
products containing the intracellular domain (e.g., full-
length, p120, NICD). The expression of the NICD protein,
indicated by increased IC immunoreactivity in the nucleus
of neural progenitor cells of the NPC-NICD telencephalon
relative to the control, becomes clear at E11.5. In the
control telencephalon, the predominant pattern of the IC
immunoreactivity was perinuclear (Figs. 1I and K). The IC
immunoreactivity in the nucleus, which corresponds to the
endogenous NICD, was barely detectable (Fig. 1K). In the
NPC-NICD telencephalon, the perinuclear immunoreactiv-
ity was similar to the control, but the IC immunoreactivity
in the nucleus was slightly more intense compared to the
control (Figs. 1J, L, and M), consistent with the Western
result showing very low levels of NICD expressed in these
mice. The specificity of the IC antiserum for Notch1 was
confirmed by the greatly diminished IC immunoreactivity
in neural progenitor cells deficient in Notch1, as shown in
Fig. 5.
Extensive apoptosis in neural progenitor cells of
NPC-NICD mice
NPC-NICD mice between E9.0 and 13.5 were obtained
at the expected Mendelian ratio. Although some NPC-NICD
mice died in utero, most of them survived to the perinatal
stage. The brain, particularly the cerebral cortex, of NPC-
NICD mice at postnatal day 0 was much smaller (Figs. 2A
and B). At E12.0–13.5, it was already evident that the
telencephalon of NPC-NICD mice was smaller than the
control (Figs. 2C and D). Histological examination of NPC-and B) Immunostaining of control and PN-NICD (CALSL-NICD;Syn-Cre)
rons in the cortical plate of the PN-NICD telencephalon. (C and D) TUNEL
m.
Fig. 5. Reduction of apoptotic cell death in N1 cKO and PS1/ mice at
E10.0. (A and B) Immunohistochemical analysis of Notch1 expressions
using IC antiserum. Notch1 protein is markedly reduced in N1 cKO mice in
the forebrain–midbrain junction at E10.0 (B). (C and D) TUNEL analysis
on comparable brain sections from N1 cKO and littermate control embryos.
Apoptotic cells are enriched in the forebrain–midbrain junction (C and D).
TUNEL-positive cells are greatly reduced in the N1 cKO brain (D). (E and
F) TUNEL-positive cells are also greatly reduced in the PS1/ brain. (G)
Quantification of the percentage of TUNEL+ cells to neural progenitor cells
(NPC) in the forebrain–midbrain junction of comparable brain sections of
N1 cKO, PS1/, and control mice. Scale bar: 200 Am.
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E12.5–13.5 revealed that all brain subregions were signif-
icantly reduced in size (Figs. 2E and F). Fewer postmitotic
neurons labeled by MAP2 immunoreactivity were detected
in the NPC-NICD brain at this age (data not shown). In
addition, the ventricular zone harboring neural progenitor
cells was thinner in the NPC-NICD brain (Figs. 2E and F,
data not shown).
The presence of pyknotic nuclei shown by TOPRO-3
staining (Fig. 1L) and the reduction of neural progenitor
population in NPC-NICD mice prompted us to determine
whether there is an increase in apoptotic cell death. At
E10.0, the TUNEL assay showed an increase in the number
of apoptotic cells in the forebrain–midbrain junction of
NPC-NICD mice, where Cre transcripts were expressed,
while much lower numbers of apoptotic cells were found in
the comparable region of control brains (Figs. 3A–F). The
increase in apoptosis was further confirmed by an increase
in the number of cells immunoreactive for activated Cas-
pase-3 (Figs. 3G and H). The number of TUNEL-positive
cells in this region of the NPC-NICD and control neuro-
epithelium was 95 F 32 and 26 F 6, respectively (n = 3).
By E11.5, the extent of apoptosis in the telencephalon was
more widespread, and TUNEL+ cells represented approxi-
mately 30% of all cells (Fig. 3J). Because the induction of
apoptosis in NPC-NICD mice was robust, we reasoned that
even though NICD was below detection by Western and
immunohistochemical analyses in the NPC-NICD (L) line,
the residual amount of NICD expressed in neural progenitor
cells, which could be detected by RT-PCR, should similarly
induce apoptotic cell death. Indeed, we found a 60%
increase in the number of TUNEL+ cells in the telenceph-
alon of NPC-NICD (L) mice at E11.5 (57 F 6, n = 3)
compared to the control (36 F 6, n = 3; P < 0.01). These
results show that even very low levels of NICD promote
apoptotic cell death in neural progenitor cells. However,
expression of NICD can only induce apoptotic cell death in
a subset of progenitor population.
NICD does not promote apoptosis in postmitotic neurons
To determine whether the induction of apoptosis by
NICD is restricted to dividing progenitor cells, we generated
a second cell type-specific conditional transgenic mouse
CALSL-NICD;Syn-Cre (PN-NICD) by breeding CALSL-
NICD mice with Syn-Cre mice, in which Cre is expressed
in postmitotic neurons under the control of the Synapsin I
promoter (Zhu et al., 2001). NICD was expressed highly in
postmitotic neurons of PN-NICD mice at E13.5 as visual-
ized by the IC immunoreactivity (Figs. 4A and B). In
contrast to many apoptotic cells observed in NPC-NICD
mice, expression of NICD in postmitotic neurons did not
lead to an increase in apoptosis (Figs. 4C and D). Similarly,
expression of NICD in mature pyramidal neurons under the
control of the aCaMKII promoter also failed to induce
apoptosis (XY and JS, unpublished results). Therefore,expression of NICD alone, even at much higher levels, is
insufficient to induce apoptosis. Neural progenitor cells,
where Notch1 is expressed at higher levels relative to
postmitotic neurons, appear to be more sensitive to alter-
ations in NICD levels. These results demonstrate that
expression of NICD selectively induces apoptotic cell death
in dividing progenitor cells but not in postmitotic (immature
or mature) neurons.
Attenuation of Notch signaling reduces apoptosis in early
neural progenitor cells
Gain-of-function approaches used in our study and many
others (Chambers et al., 2001; Furukawa et al., 2000;
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Scheer et al., 2001; Tanigaki et al., 2001) by forced
expression of NICD have their intrinsic limitations and
may reveal nonphysiological activities of Notch. To com-
plement our gain-of-function studies and to assess the role
of Notch signaling in cell death, we employed the Cre/loxP
recombination system to generate a Notch1 conditional
knockout (N1 cKO) mouse. We first generated a floxed
N1 (fN1) mouse in which two loxP sites were introduced to
flank the first coding exon of Notch1. The fN1 mouse was
then bred to the Nes-Cre mouse to generate N1 cKO mice.
Immunohistochemical analysis at E10.0 and E11.5 revealed
greatly reduced IC immunoreactivity in neural progenitor
cells of N1 cKO mice relative to control (Figs. 5A and B,
data not shown).
Brains of N1 cKO and littermate controls (fN1/+) were
examined for cell death at E10.0. TUNEL analysis of
comparable brain sections of N1 cKO and control embryos
revealed significantly reduced numbers of apoptotic cells in
the forebrain–midbrain junction of N1 cKO mice (19 F 2)
compared to control (39 F 8, n = 4) (Figs. 5C and D).
Because reduced Notch signaling is known to cause prema-
ture neuronal differentiation and reduction of the progenitor
population (de la Pompa et al., 1997; Handler et al., 2000;
Hitoshi et al., 2002; Shen et al., 1997), we sought to
determine whether the reduction in the absolute number of
TUNEL+ cells could be secondary to a reduction in the
number of neural progenitor cells in N1 cKO mice. We
therefore determined the number of neural progenitor cells
by subtracting TuJ1+ neurons from total cell numbers and
then calculated the ratio of TUNEL+ apoptotic cells to
TuJ1-negative neural progenitor cells. We found that the
percentage of apoptotic cells relative to all progenitor cells
is reduced by approximately 50% in the forebrain–midbrainFig. 6. Neuronal differentiation in N1 cKO and NPC-NICD mice. (A–C) Immun
cKO (B), and NPC-NICD (C) mice using TuJ1 antibodies. (B) Increased neuro
diencephalon (arrow head), while in C, reduced number of neurons is observed
compared to control (A). Scale bar: 200 Am.junction of N1 cKO mice (5.1 F 0.4%, n = 4) relative to
control (11.5 F 2.2%, n = 4; P < 0.01) (Fig. 5G).
We previously showed that the intramembrane cleavage
of Notch1 is reduced in PS1/ cells (Song et al., 1999),
and that Notch activity is attenuated in PS1/ brains, as
evidenced by downregulation of Notch downstream effector
Hes5 and upregulation of Notch ligand Dll1 (Handler et al.,
2000). TUNEL analysis of comparable brain sections of
PS1/ and control embryos at E10.0 revealed an approx-
imately 50% reduction in apoptotic cells in the forebrain–
midbrain junction of PS1/mice (13 F 5, n = 5) relative
to control (30 F 8, n = 6; P < 0.005) (Figs. 5E and F). The
percentage of apoptotic cells to progenitor cells in this
region is also reduced by approximately 50% in PS1/
mice (4.4 F 1.5%, n = 5) relative to control (10.2 F 2.5%, n
= 6; P < 0.005) (Fig. 5G). These results are consistent with
the observation showing reduced apoptosis in N1 cKO mice,
providing further evidence supporting for Notch1 serving as
a key target of PS1 in the regulation of early neural
development.
Although it is possible that reductions in apoptotic cell
death in these loss-of-function mutant mice could result in
a higher number of neural progenitor cells, which over
time could affect the ratio of apoptotic cells to total
progenitor cells, this is unlikely the case in the present
study for the following reasons. First, we examined cell
death at E10.0, immediately after the Cre transgene is
expressed in this area (the midbrain–forebrain junction) at
E9.5. Therefore, this effect should be at the minimum at
this early developmental stage. Second, the absolute num-
ber of progenitor cells is quite comparable between mutant
and control mice at this age, and the relatively low
percentages of cell death observed (approximately 5% for
mutants and approximately 10% for controls) would not beohistochemical analysis on comparable brain sections from control (A), N1
nal differentiation is observed in the N1 cKO telencephalon (arrow) and
in the NPC-NICD telencephalon (arrow) and diencephalon (arrow head)
Fig. 7. Activation of the p53 pathway in NPC-NICD mice. (A–D)
Immunohistochemical analysis of control and NPC-NICD brains at E10.5
and E11.5. Levels of p53 are highly elevated in the nucleus of neural
progenitor cells in NPC-NICD brains in contrast to very low levels of p53
in the control. (E) Quantitative real-time RT-PCR analysis of Bax and Noxa
expression at E11.5. The y-axis represents the fold change of mRNA levels
in NPC-NICD brains relative to the control. Expression of Bax and Noxa is
increased (approximately 2- and 6-fold, respectively) in NPC-NICD brains
(n = 3–5). (F) Confocal microscopy analysis of p53+ cells (green) and
newly generated postmitotic neurons labeled by TuJ1 (red) in NPC-NICD
mice. Most, if not all, p53+ cells are immunonegative for TuJ1. Scale bar:
100 Am.
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overall progenitor population. Third, the magnitude of
the difference in percent cell death between genotypes
(approximately 50%) is quite large in comparison to the
relatively low rate of cell death observed (5–10%), indi-
cating that any minor inaccuracies in estimation of actual
cell death rates would not alter our conclusions.
By E11.5, the naturally occurring apoptosis in all areas
became much less frequent, and few TUNEL+ cells were
detected in the control telencephalon (Fig. 3I). No signifi-
cant difference in the number of TUNEL+ cells was
observed in the telencephalon of control and N1 cKO mice,
consistent with our previous studies indicating that there
was no significant difference in the number of apoptotic
cells in the telencephalon of PS1/ and littermate controls
at E11.5 and 12.5 (Handler et al., 2000). More postmitotic
neurons labeled by TuJ1 were found in the telencephalon
and diencephalon of N1 cKO mice (Figs. 6A and B), which
is in agreement with our previous study showing that
reduction of Notch activity in PS1/ mice results in
premature neuronal differentiation at this age (Handler et
al., 2000). On the other hand, fewer TuJ1-positive differen-
tiated neurons were present in NPC-NICD telencephalon
and diencephalon (Fig. 6C), resulting from reduction of the
progenitor population and possibly inhibition of neuronal
differentiation by NICD.
NICD activates the p53 tumor suppression pathway
We next looked for the molecular mechanism by which
constitutive activation of Notch signaling could lead to
apoptotic cell death. Constitutive expression of Notch
signaling, caused by a naturally occurring truncation muta-
tion of human Notch1 homologue, has been shown to cause
T cell lymphoma (Ellisen et al., 1991). Expression of
oncogenes often induces apoptosis through the activation
of the p53 tumor suppression pathway (Levine, 1997). We
therefore examined NPC-NICD brains to determine whether
levels of p53 were elevated. In contrast to very low levels of
p53 in the control brain, highly elevated levels of nuclear
p53 immunoreactivity were observed in the progenitor cells
of NPC-NICD mice at E10.5 and E11.5 (Figs. 7A–D).
Double-labeling analysis using antibodies specific for p53
and h-tubulin III showed that most, if not all, of p53+ cells
did not express h-tubulin III, confirming that p53 upregu-
lation occurred in neural progenitor cells (Fig. 7F).
p53 responds to oncogenic stimuli by inducing apoptosis
through the activation of target effector genes, which
include Bax (Miyashita and Reed, 1995) and Noxa (Oda
et al., 2000). These gene products, which contain the BH3-
domain, can bind to Bcl-2 and antagonize its function,
resulting in cytochrome c release from mitochondria and
activation of the apoptosis cascade. To confirm functional
upregulation of the p53 pathway, we examined whether
elevated levels of nuclear p53 in NPC-NICD mice would
lead to increased expression of Bax and Noxa, which are thebetter known downstream targets of the p53-mediated
apoptosis pathway (Vousden, 2000). Quantitative real-time
RT-PCR analysis of NPC-NICD and control brains at E11.5
revealed significant increases in Bax (180 F 33%, P < 0.05)
and Noxa (550 F 112%, P < 0.005) expression in the NPC-
NICD brain (Fig. 7E). Thus, elevated levels of nuclear p53
in these mice also lead to transcriptional activation of p53-
responsive apoptotic effector genes, providing a molecular
mechanism for the induction of apoptosis by NICD.
p53 deficiency suppresses apoptosis induced by NICD
To determine whether NICD induces apoptosis through a
p53-dependent pathway, we crossed CALSL-NICD;Nes-Cre
mice to the p53/ background (Jacks et al., 1994) and
examined whether inactivation of p53 can block the exten-
sive apoptotic cell death in NPC-NICD brains. CALSL-
Fig. 8. p53 deficiency suppresses apoptotic cell death in NPC-NICD mice. TUNEL analysis at E11.5 reveals extensive apoptotic cell death in the telencephalon
of CALSL-NICD;Nes-Cre and CALSL-NICD;Nes-Cre;p53+/ mice. In contrast, few apoptotic cells are detected in the telencephalon of CALSL-NICD;Nes-
Cre;p53/, p53/, and CALSL-NICD;p53+/ mice. Scale bar: 200 Am.
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between CALSL-NICD;p53+/ and Nes-Cre;p53+/ mice
at a frequency lower than the expected Mendelian ratio (1/
16) due to the incomplete penetrance of early embryonic
lethality associated with p53/ deficiency (Armstrong
et al., 1995). TUNEL analysis of CALSL-NICD;Nes-
Cre;p53/ mice at E10.5–11.5 revealed that the dramatic
increase in apoptotic cells observed in CALSL-NICD;Nes-
Cre brains was completely blocked by inactivation of p53 in
these mice (Fig. 8). Removal of one p53 allele in CALSL-
NICD;Nes-Cre;p53+/ brains, however, appeared to have
no effect on the suppression of the extensive apoptosis.
These results show that NICD induces apoptosis in neural
progenitor cells via the p53-dependent pathway.Discussion
Notch1 regulates apoptotic cell death in mammalian early
neural progenitor cells
Notch has been reported to regulate apoptosis in inter-
ommatidial precursor cells of the developing retina (Cagan
and Ready, 1989; Miller and Cagan, 1998) and sensory
organ primary precursor cells (Orgogozo et al., 2002) during
Drosophila development. Similarly, Notch activation causes
retinal cells to enter apoptosis in the zebrafish retina (Scheer
et al., 2001). However, it was unknown whether Notch
signaling is involved in the regulation of apoptotic cell death
during mammalian neural development, in addition to its
well-established roles in neurogenesis (Schuurmans and
Guillemot, 2002). We therefore used unbiased genetic
approaches to address this important question because
modulation of apoptosis contributes to the final determina-
tion of the brain size and its shape (Kuan et al., 2000).
In the present study, we employed complementary con-
ditional transgenic and knockout approaches to determine
the effects of up- or downregulation of Notch signaling on
apoptotic cell death in neural progenitor cells. We show that
expression of even very low levels of NICD in early neural
progenitors induces extensive apoptosis and results in a
markedly reduced progenitor population and ultimately a
smaller brain (Figs. 2 and 3). The promotion of cell death by
NICD is restricted to a narrow temporal window: itsexpression in immature or mature neurons even at much
higher levels in CALSL-NICD;Syn-Cre, aCaMKII-NICD, or
CALSL-NICD;aCaMKII-Cre mice fails to promote cell
death (Fig. 4, XYand JS, unpublished results). These results
are consistent with previous findings showing that NICD
induces extensive apoptosis in the zebrafish retina, particu-
larly when expressed at an early stage (Scheer et al., 2001),
demonstrating a conserved pro-apoptotic role of Notch
activation in neural progenitor cells in vertebrates.
However, the gain-of-function approach widely used in
Notch function studies has its intrinsic limitations and may
reveal nonphysiological functions. We therefore generated
and analyzed Notch1 conditional KO mice in which Notch1
inactivation is restricted to neural progenitor cells. We found
that attenuation of Notch activity in N1 cKO and PS1/
mice results in a marked (approximately 50%) reduction in
the apoptotic death of early neural progenitor cells at E10
(Fig. 5). These results corroborate our findings from NPC-
NICD mice, supporting a physiological role of Notch
signaling in the regulation of apoptotic cell death during
early mammalian neural development.
As seen in NPC-NICD mice, loss of Notch1 function
also influences cell death in neural progenitors in a narrow
temporal window (narrower than NICD): while compared to
the control, the number of apoptotic cells in N1 cKO or
PS1/ mice is reduced at E10, but unchanged at E11.5.
Combined, our results indicate that Notch1 activity selec-
tively affects apoptotic cell death in early neural progenitors.
One explanation for this observation is that under normal
physiological conditions, early neural progenitor cells at
E10 are more sensitive than progenitor cells at E11.5 to cell
death-promoting signals. Precedents for such context-de-
pendent protection from apoptotic cell death promoted by
Notch signaling have been reported in the Drosophila
interommatidial lattice (Cagan and Ready, 1989; Miller
and Cagan, 1998).
NICD induces apoptosis in neural progenitor cells via a
p53-dependent pathway
The increased frequency of apoptotic cell death in NPC-
NICD mice allowed us to probe the underlying molecular
pathways. Previous studies in Drosophila (Milan et al.,
2002; Miller and Cagan, 1998; Orgogozo et al., 2002) and
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not explore the involvement of p53 pathway in cell death
induced by Notch. Here, we show that a p53-dependent
pathway is activated in neural progenitor cells in association
with the extensive apoptotic cell death induced by Notch
activation. This is evidenced by the markedly increased
immunoreactivity of p53 in the nucleus of neural progenitor
cells in NPC-NICD mice (Fig. 7). Further, we observed
significant transcriptional upregulation of Bax and Noxa,
two major genes mediating p53-dependent apoptotic cell
death (Fig. 7), although the direct link between p53 and
Bax–Noxa is not shown in the present study. Genetic rescue
experiment unequivocally demonstrates that p53 deficiency
is sufficient to suppress the increased cell death phenotype
caused by Notch activation (Fig. 8).
These results agree with the current view that p53 family
members participate in embryonic development in mice
(Yang et al., 2002), in addition to their role in tumor
suppression in adult tissues. Mice deficient for p63, a
homologue of p53, lack limbs and a wide range of epithelial
structures including skin, prostate, breast, and urothelia
(Mills et al., 1999; Yang et al., 1999). Inactivation of
another p53 homologue, p73, results in congenital hydro-
cephalus and hippocampal dysgenesis, presumably due to
disappearance of Cajal-Retzius neurons (Yang et al., 2000).
p53 and its downstream target Bax have been shown to be
highly expressed and colocalize in the ventricular and
subventricular zone at embryonic and early postnatal stages
in mice (van Lookeren Campagne and Gill, 1998). p53/
mice have an incomplete penetrant phenotype: although
some survive into adulthood, approximately 40% of the
embryos display severe defects in neural tube closure
(Armstrong et al., 1995; Sah et al., 1995), suggesting that
other family members, such as p63 and p73, may compen-
sate for the lack of p53 in the proper development of the
nervous system.
It is not yet clear how Notch triggers p53 activation and
the downstream apoptotic cascades in neural progenitor
cells. Several possibilities exist. First, a constitutively active
form of Notch1 can act as an oncogene in neural progenitor
cells, as reported in nonneural cell types (Ellisen et al.,
1991; Jhappan et al., 1992). We did observe an increase in
proliferation at E11.5 in NPC-NICD; p53/ (55.0 F
4.5%) compared to CALSL-NICD; p53/ mice (44.3 F
2.0%, P < 0.05), as measured by the ratio of BrdU-labeled
cells to all progenitor cells. The proliferation rate of the
dying p53+ progenitor cells (BrdU+/p53+) is also higher
than that of live progenitor cells (BrdU+/Ki67+). These
observations are consistent with our hypothesis that Notch
activation increases proliferation and results in apoptotic cell
death in a subset of progenitor cells. Second, Notch may act
as a specification signal for cell death. However, the
programmed cell death induced by Notch activation is only
limited to a subpopulation of neural progenitor cells (ap-
proximately 30% in the NPC-NICD telencephalon at
E11.5). Further, Notch activation in other cell types, suchas postmitotic neurons (this study), cultured adult neural
progenitor cells (Tanigaki et al., 2001), or neural crest stem
cells (Morrison et al., 2000), does not lead to increased cell
death. Therefore, expression of NICD per se appears insuf-
ficient to induce apoptosis. Third, in NPC-NICD mice, we
observed ectopically expressed NeuroD transcripts distrib-
uted in the forebrain–midbrain junction at E10.0 and in the
ventricular zone of the telencephalon at E11.5 (XY and JS,
unpublished results). However, we did not observe any
increase in terminally differentiated neurons labeled by
TuJ1 or MAP2 (Fig. 6, data not shown). It is therefore
possible that higher levels of NICD in NPC-NICD mice
may prevent these NeuroD-expressing cells from comple-
tion of differentiation and trigger the apoptosis cascade.
Finally, Notch activation may also act in opposition of
trophic or survival factors that are essential at early devel-
opmental stages (E10) but become redundant at later stages
(E11.5). It has been shown that the pro-apoptotic role of
Notch blocks EGFR-dependent survival signaling in the
Drosophila retina (Miller and Cagan, 1998; Yu et al., 2002).
In conclusion, although the exact mechanism is not yet
completely clear, Notch activation induces apoptosis in a
subset of neural progenitor cells by activation of the p53
pathway.
Notch1 regulates mammalian neural development in a
context-dependent manner
Our observation that Notch activation promotes cell
death in neural progenitor cells appears to be at odds with
one previous study showing that expression of NICD
promotes radial gliogenesis (Gaiano et al., 2000). In both
studies, NICD is expressed in telencephalic neural progen-
itor cells beginning at E9, although the methodologies by
which NICD was introduced differ. Our genetic approach
allows expression of NICD in most, if not all, progenitor
cells, while their retroviral infection approach limits NICD
expression to a small percentage of the progenitor cells. In
addition, their use of a reporter gene to identify infected
cells essentially restricts subsequent analysis to surviving
cells, selecting a subset cell population that does not
respond to Notch activation with cell death. Therefore, it
is likely that the cell death induced by NICD was uninten-
tionally overlooked in the infection experiment, but was
better revealed by our genetic experiment. Furthermore, our
present genetic study is in agreement with prior genetic
studies in Drosophila and zebrafish, all showing that Notch
signaling regulates programmed cell death during develop-
ment (Cagan and Ready, 1989; Miller and Cagan, 1998;
Orgogozo et al., 2002; Scheer et al., 2001).
Although our transgenic approach is advantageous in
revealing apoptotic cell death, the resulting depletion of
neural progenitor cells makes it difficult to determine
conclusively the effects of NICD expression on neuronal
differentiation. Expression of NICD in NPC-NICD mice
results in a reduction in postmitotic neurons (Fig. 6C),
X. Yang et al. / Developmental Biology 269 (2004) 81–9492which could be explained by depletion of progenitor cells
caused by increased apoptosis or suppression of neuronal
differentiation. Due to the very early expression of NICD at
the onset of neurogenesis, NPC-NICD mice are not good
models for the study of the effect of Notch activation on
gliogenesis. Although introduction of NICD into other types
of progenitors by retroviral vectors has been shown to
promote gliogenesis (Furukawa et al., 2000; Morrison et
al., 2000; Tanigaki et al., 2001), the expression of NICD in
our study and these previous reports differs in cell type
(early neural progenitors of the developing brain versus
other progenitor types such as neural crest cells of the PNS),
timing (E9.5 versus later stages), or extent (all progenitors
versus a small percentage of progenitors). Because Notch
can activate the GFAP promoter and promote astroglial fates
only during the gliogenesis phase (Ge et al., 2002; Tanigaki
et al., 2001), it is not surprising that we did not observe an
increase in radial glia or astrocytes in NPC-NICD mice
during the neurogenesis phase (XY and JS, unpublished
results). At later developmental stages, the extensive loss of
the progenitor cells makes it too difficult to determine the
impact of NICD on gliogenesis. Theoretically, the role of
Notch1 in neurogenesis and gliogenesis can be studied in
NPC-NICD mice in the p53/ background in which cell
death is suppressed. However, p53/ embryos display a
variety of neurodevelopmental defects with incomplete
penetrance (Armstrong et al., 1995; Sah et al., 1995),
rendering it difficult to discern the phenotypes caused by
Notch activation alone.
In summary, Notch signaling regulates neurogenesis,
gliogenesis, and apoptotic cell death in a highly context-
dependent manner. Notch activation consistently suppresses
neurogenesis and promotes alternative cell fates by mainte-
nance of the progenitor state, promotion of glial cell types,
or induction of apoptotic cell death in a manner dependent
upon the spatial and temporal context. Thus, our results
provide an important addition to the previously described
function of Notch signaling in the suppression of terminal
neuronal differentiation during the neurogenesis phase and
promotion of terminal glial differentiation during the glio-
genesis phase, demonstrating a crucial role for Notch in the
regulation of apoptosis in early neural progenitors through a
p53-dependent mechanism.Acknowledgments
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